International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-5 doi: 10.5281/zenodo.12987899
Original Research Article
Surgical Site Infection Rates and Risk Factors in Elective Laparoscopic Cholecystectomies: A Prospective Observational Study
Published
Oct. 30, 2024
Abstract

Background: Surgical site infections (SSIs) are a common complication following elective laparoscopic cholecystectomy. Identifying the incidence and risk factors associated with SSIs is crucial for improving surgical outcomes. Objective: To determine the incidence of SSIs and identify the risk factors associated with infections in patients undergoing elective laparoscopic cholecystectomy. Methods: A prospective observational study was conducted with 50 patients who underwent elective laparoscopic cholecystectomy. Demographic data, surgical details, and postoperative outcomes were recorded. SSIs were classified into superficial, deep incisional, and organ/space infections. Risk factors such as diabetes, BMI, smoking, and operative time were analyzed using statistical methods. Results: The overall incidence of SSIs was 10%, with 5 patients developing infections: 3 superficial (6%), 1 deep incisional (2%), and 1 organ/space infection (2%). Diabetes was significantly associated with SSIs (30%, p = 0.02), as was obesity (BMI >30) with 25% of obese patients affected (p = 0.03). Prolonged operative time (>120 minutes) was another significant risk factor (33.3%, p = 0.01). Smoking showed a trend toward increased infection risk but was not statistically significant (25%, p = 0.08). Common pathogens included Escherichia coli, Staphylococcus aureus, and Klebsiella pneumoniae. Two of the infections involved antibiotic-resistant organisms. Conclusion: The incidence of SSIs in elective laparoscopic cholecystectomy was 10%, with diabetes, obesity, and prolonged operative time being significant risk factors. Prophylactic antibiotic use was effective in reducing infection rates. Identifying high-risk patients can help tailor preventative strategies to reduce SSI incidence.

Recommended Articles
Loading Image...
Volume-5, Issue-5
Citations
890 Views
325 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved